Trials reveal efficacy and safety of oral drug for treating anemia associated with kidney disease
Pooled results from phase 3 clinical trials demonstrate that roxadustat is efficacious and may be comparable to placebo in studies done to date for treating anemia in patients with chronic kidney disease who do not require dialysis. …read more
